Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Inovio Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
INO
Nasdaq
8731
https://www.inovio.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Inovio Pharmaceuticals Inc
INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine
- Mar 26th, 2024 10:28 pm
Does Inovio (INO) Have the Potential to Rally 122.92% as Wall Street Analysts Expect?
- Mar 8th, 2024 2:55 pm
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2023 Earnings Call Transcript
- Mar 7th, 2024 3:38 pm
Q4 2023 Inovio Pharmaceuticals Inc Earnings Call
- Mar 7th, 2024 11:39 am
Inovio Pharmaceuticals (INO) Q4 2023 Earnings Call Transcript
- Mar 7th, 2024 4:30 am
INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
- Mar 6th, 2024 9:05 pm
Geneos Therapeutics to Present New Clinical Data on GNOS-PV02 at the 2024 American Association for Cancer Research (AACR) Annual Meeting
- Mar 6th, 2024 12:00 pm
Wall Street Analysts Predict a 146.39% Upside in Inovio (INO): Here's What You Should Know
- Feb 21st, 2024 2:55 pm
INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024
- Feb 21st, 2024 1:00 pm
Inovio (INO) Moves 17.4% Higher: Will This Strength Last?
- Feb 12th, 2024 11:25 am
INOVIO to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
- Feb 7th, 2024 4:46 pm
INOVIO Reports Inducement Grant Under Inducement Plan
- Feb 2nd, 2024 1:00 pm
How Much Upside is Left in Inovio (INO)? Wall Street Analysts Think 223.72%
- Jan 30th, 2024 2:55 pm
INOVIO Announces Effective Date of 1-for-12 Reverse Stock Split
- Jan 23rd, 2024 1:00 pm
INOVIO to Participate in Virtual Fireside Chat on the Potential Treatment of Recurrent Respiratory Papillomatosis with Key Opinion Leader
- Jan 22nd, 2024 1:00 pm
Inovio Pharma (INO) Stock Rallies 134% in a Month: Here's Why
- Jan 12th, 2024 2:43 pm
INOVIO and Coherus Announce Clinical Collaboration to Advance Development of INO-3112 in Combination with LOQTORZI⢠(toripalimab-tpzi)
- Jan 4th, 2024 1:00 pm
INOVIO Plans to Submit a BLA for INO-3107 as a Potential Treatment for RRP in Second Half of 2024 Under Accelerated Approval Program
- Jan 3rd, 2024 1:00 pm
The 3 Most Undervalued Biotech Stocks to Buy: November 2023
- Nov 14th, 2023 3:56 pm
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q3 2023 Earnings Call Transcript
- Nov 10th, 2023 8:38 pm
Scroll